搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Yarrowia lipolytica Translation factor GUF1, mitochondrial (GUF1), partial CSB-YP738272YAP
CSB-EP738272YAP
CSB-BP738272YAP
CSB-MP738272YAP
CSB-EP738272YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica mRNA-capping enzyme subunit beta (CET1) CSB-YP738273YAP
CSB-EP738273YAP
CSB-BP738273YAP
CSB-MP738273YAP
CSB-EP738273YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica WD repeat-containing protein JIP5 (JIP5) CSB-YP738274YAP
CSB-EP738274YAP
CSB-BP738274YAP
CSB-MP738274YAP
CSB-EP738274YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Endoribonuclease YSH1 (YSH1), partial CSB-YP738275YAP
CSB-EP738275YAP
CSB-BP738275YAP
CSB-MP738275YAP
CSB-EP738275YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Leukotriene A-4 hydrolase homolog (YALI0F00396g), partial CSB-YP738276YAP
CSB-EP738276YAP
CSB-BP738276YAP
CSB-MP738276YAP
CSB-EP738276YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Protein transport protein SEC31 (SEC31), partial CSB-YP738277YAP
CSB-EP738277YAP
CSB-BP738277YAP
CSB-MP738277YAP
CSB-EP738277YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica U3 small nucleolar RNA-associated protein 10 (UTP10), partial CSB-YP738278YAP
CSB-EP738278YAP
CSB-BP738278YAP
CSB-MP738278YAP
CSB-EP738278YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Eukaryotic translation initiation factor 3 subunit F (YALI0E26851g) CSB-YP738279YAP
CSB-EP738279YAP
CSB-BP738279YAP
CSB-MP738279YAP
CSB-EP738279YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Autophagy protein 5 (ATG5) CSB-YP738280YAP
CSB-EP738280YAP
CSB-BP738280YAP
CSB-MP738280YAP
CSB-EP738280YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Peptidyl-prolyl cis-trans isomerase B (CPR2) CSB-YP738281YAP
CSB-EP738281YAP
CSB-BP738281YAP
CSB-MP738281YAP
CSB-EP738281YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Uncharacterized protein YAE1 (YAE1) CSB-YP738282YAP
CSB-EP738282YAP
CSB-BP738282YAP
CSB-MP738282YAP
CSB-EP738282YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Histone-lysine N-methyltransferase, H3 lysine-36 specific (set-2), partial CSB-YP738283YAP
CSB-EP738283YAP
CSB-BP738283YAP
CSB-MP738283YAP
CSB-EP738283YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica DNA replication complex GINS protein PSF2 (PSF2) CSB-YP738284YAP
CSB-EP738284YAP
CSB-BP738284YAP
CSB-MP738284YAP
CSB-EP738284YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Chromatin modification-related protein EAF6 (EAF6) CSB-YP738285YAP
CSB-EP738285YAP
CSB-BP738285YAP
CSB-MP738285YAP
CSB-EP738285YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Ribosome biogenesis protein NSA2 (NSA2) CSB-YP738286YAP
CSB-EP738286YAP
CSB-BP738286YAP
CSB-MP738286YAP
CSB-EP738286YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica DNA polymerase epsilon subunit C (DPB3) CSB-YP738287YAP
CSB-EP738287YAP
CSB-BP738287YAP
CSB-MP738287YAP
CSB-EP738287YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Probable thiopurine S-methyltransferase (YALI0E05467g) CSB-YP738288YAP
CSB-EP738288YAP
CSB-BP738288YAP
CSB-MP738288YAP
CSB-EP738288YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Exportin-T (LOS1), partial CSB-YP738289YAP
CSB-EP738289YAP
CSB-BP738289YAP
CSB-MP738289YAP
CSB-EP738289YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Pre-mRNA polyadenylation factor FIP1 (FIP1) CSB-YP738290YAP
CSB-EP738290YAP
CSB-BP738290YAP
CSB-MP738290YAP
CSB-EP738290YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Protein CGI121 (CGI121) CSB-YP738291YAP
CSB-EP738291YAP
CSB-BP738291YAP
CSB-MP738291YAP
CSB-EP738291YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>